TRxADE Health Inc reports results for the quarter ended in March - Earnings Summary

Scienture Holdings

15/05/2023 22:44

* TRxADE Health Inc  MEDS.OQ  reported a quarterly adjusted
loss
of 7 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 4 cents per share.
    * Revenue fell 30.6% to $2.25 million from a year ago;
analysts
expected $2.66 million. 
    * TRxADE Health Inc's reported EPS for the quarter was a
loss of 3
cents​.
    * The mean earnings estimate of analysts had risen by
about 20% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TRxADE Health Inc shares had risen by 30.1% this
quarter and
lost 4.7% so far this year.
    * The company reported a quarterly loss of $326 thousand.
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $1.70 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 09:44 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.04          -0.07          Missed
 Dec. 31 2022      -0.06          -0.01          Beat
 Sep. 30 2022      -0.12          -0.06          Beat
 Jun. 30 2022      -0.10          -0.13          Missed